Clinical Trial Update: Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Vivomixx probiotics on weight, microbiota, and glucose tolerance in obese pregnant women and their newborns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus
• Obesity
• Pregnancy

Drugs mentioned

• Vivomixx (Probiotic formulation)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Pregnancy, Obesity | Phase 4 | Status: COMPLETED